EligibleTrials

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Recruiting · NCT07290036 · Interventional (participants receive a specific treatment) · Lead sponsor: UCB Biopharma SRL

View the official record on ClinicalTrials.gov →
Psoriasis

Interventions studied

Bimekizumab regimen 1 ivBimekizumab regimen 2 ivBimekizumab regimen 3 sc

What this trial is about

To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

60 locations listed across 15 US states.

Showing 60 of 63 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.